Clinical Trials Browser

Phase 4 × Lung Neoplasms × Nivolumab × Clear all

NCT02869789 2023-06-15

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Phase 4 Completed

1,041 enrolled 18 charts

Lung Neoplasms

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Phase 4 Unknown

DermatologicThoracic

Lung Neoplasms, Melanoma